Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|8|8|753-764
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.8, Iss.8, 2008-12, pp. : 753-764
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Selective COX-2 inhibitors vs NSAIDs discussed
Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. :
COX-2 use grows despite little added benefit over NSAIDs
Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. :
CV disorder risks extend beyond COX-2-selectivity of NSAIDs
Reactions Weekly, Vol. 1, Iss. 1170, 2007-01 ,pp. :
COX-2 use grows despite little added benefit over NSAIDs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :